ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma
- PMID: 3886828
- PMCID: PMC2187613
- DOI: 10.1084/jem.161.5.1213
ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma
Abstract
ras Oncogene p21 antigen is present in the most superficial cells of the normal bladder urothelium, as demonstrated by immunohistochemical staining. The pattern and intensity of p21 staining of cells in epithelial hyperplasia and low grade bladder carcinoma were similar to that seen in the normal urothelium. In contrast, epithelial cells in "premalignant" (dysplastic) lesions and high grade carcinomas exhibited an intense staining reaction for p21 antigen. ras p21 may be a useful marker for the malignant potential of both premalignant lesions and carcinomas of the bladder.
Similar articles
-
Immunohistochemical study of the ras oncogene expression in human bladder endoscopy specimens.Eur J Surg Oncol. 1990 Apr;16(2):153-60. Eur J Surg Oncol. 1990. PMID: 2182341
-
Expression of ras p21 oncogene product on human bladder tumors.Urol Int. 1989;44(5):260-3. doi: 10.1159/000281520. Urol Int. 1989. PMID: 2678672
-
Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum.Br J Cancer. 1985 Nov;52(5):695-700. doi: 10.1038/bjc.1985.245. Br J Cancer. 1985. PMID: 3904802 Free PMC article.
-
Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.Hum Pathol. 2010 Feb;41(2):155-62. doi: 10.1016/j.humpath.2009.07.002. Epub 2009 Sep 16. Hum Pathol. 2010. PMID: 19762067 Review.
-
[Preneoplastic lesions and precursors of urothelial cancer].Pathologe. 2016 Feb;37(1):33-9. doi: 10.1007/s00292-015-0130-z. Pathologe. 2016. PMID: 26811248 Review. German.
Cited by
-
Immunocytochemical localization of ras p21 product in thyroid follicular cells of normal rats using monoclonal antibody RAP-5.Histochem J. 1988 Nov;20(11):629-34. doi: 10.1007/BF01324082. Histochem J. 1988. PMID: 3066790
-
Molecular biology of dissemination in bladder cancer--laboratory findings and clinical significance.World J Urol. 1996;14(3):190-6. doi: 10.1007/BF00186899. World J Urol. 1996. PMID: 8806198 Review.
-
Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines.Br J Cancer. 1992 Aug;66(2):304-10. doi: 10.1038/bjc.1992.261. Br J Cancer. 1992. PMID: 1503903 Free PMC article.
-
Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma.Urol Res. 1991;19(6):361-6. doi: 10.1007/BF00310151. Urol Res. 1991. PMID: 1759330
-
Bladder cancer: the molecular progression to invasive disease.World J Urol. 1994;12(2):89-95. doi: 10.1007/BF00184243. World J Urol. 1994. PMID: 7916240 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical